ZLAB News and Press, Zai Lab Limited From 02/08/24

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 7.9% to $23.6 on volume of 254,911,069 shares MicroCloud Hologram Inc. (HOLO) rose 1092.1% to $18 on volume of 194,069,467 shares Snap Inc. Class A (SNAP) fell 34.6% to $11.41 on volume o...

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.5% to $23.725 on volume of 224,436,172 shares MicroCloud Hologram Inc. (HOLO) rose 602.0% to $10.6 on volume of 173,635,213 shares Snap Inc. Class A (SNAP) fell 34.8% to $11.37 on volum...

2024-02-07 11:28:54 ET More on I-Mab Biopharma Seeking Alpha’s Quant Rating on I-Mab Biopharma Historical earnings data for I-Mab Biopharma Financial information for I-Mab Biopharma Read the full article on Seeking Alpha For further details see...

- Company to Host Conference Call and Webcast on February 28, 2024, at 8:00 a.m. ET (9:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the year ended December 31, 2023 and recent corporate updates, after the closing of ...

2024-01-23 12:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-22 10:00:11 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-18 07:24:27 ET More on NovoCure, Zai Lab, etc. Zai Lab: Strong Growth Amidst Strategic Shifts (Rating Upgrade) NovoCure: Significant Upside Even Without A Breakthrough Zai Lab Limited (ZLAB) Q3 2023 Earnings Call Transcript Novocure reports better-tha...

Phase 1/2 TRIDENT-1 study data demonstrate repotrectinib’s clinically meaningful response rates and durable clinical activity in patients with ROS1-positive non-small cell lung cancer Data show robust intracranial activity both in TKI naïve and pretreated settings in patients ...

2023-12-30 05:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-27 14:59:02 ET More on NovoCure NovoCure: Significant Upside Even Without A Breakthrough NovoCure Limited 2023 Q3 - Results - Earnings Call Presentation NovoCure Limited (NVCR) Q3 2023 Earnings Call Transcript Novocure to eliminate 13% of workforce in...